8 WiSys Technologies in "Medical Imaging" or "Pharmaceuticals & Vitamin D"
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.
WiSys Technology Foundation is seeking a strategic partner to further develop, manufacture, market, and distribute a high accuracy rotary (angle) encoder. This device has the advantages of high single-reading accuracy (±0.1 arc seconds) and high average reading sensitivity (0.001 arc seconds), low production cost, compact design, and low power consumption. Possible applications include but are not limited to astronomical telescope mounts, land surveillance tools, industrial inspection and calibration, machine tools, medical devices, as well as robotics.
The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.
WiSys is currently seeking a strategic partner to assist in such further development providing a route to market for the commercialization of lead analogues.